Cargando…
The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
There is little recent information about the prevalence of symptomatology of mental health disorders in representative population samples in Mexico. To determine the prevalence of mental health symptoms in Mexico and its comorbidity with tobacco, alcohol, and drug use disorder (SUD), we used the 201...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961066/ https://www.ncbi.nlm.nih.gov/pubmed/36833803 http://dx.doi.org/10.3390/ijerph20043109 |
_version_ | 1784895663494922240 |
---|---|
author | Medina-Mora, María Elena Genis-Mendoza, Alma Delia Villatoro Velázquez, Jorge Ameth Bustos-Gamiño, Marycarmen Bautista, Clara Fleiz Camarena, Beatriz Martínez-Magaña, José Jaime Nicolini, Humberto |
author_facet | Medina-Mora, María Elena Genis-Mendoza, Alma Delia Villatoro Velázquez, Jorge Ameth Bustos-Gamiño, Marycarmen Bautista, Clara Fleiz Camarena, Beatriz Martínez-Magaña, José Jaime Nicolini, Humberto |
author_sort | Medina-Mora, María Elena |
collection | PubMed |
description | There is little recent information about the prevalence of symptomatology of mental health disorders in representative population samples in Mexico. To determine the prevalence of mental health symptoms in Mexico and its comorbidity with tobacco, alcohol, and drug use disorder (SUD), we used the 2016–17 National Survey of Drug, Alcohol, and Tobacco Use (Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco, ENCODAT 2016–2017). The data were collected from households using a cross-sectional, stratified, multistage design, with a confidence level of 90% and a response rate of 73.6%. The final sample included 56,877 completed interviews of individuals aged 12–65, with a subsample of 13,130 who answered the section on mental health. Symptoms of mania and hypomania (7.9%), depression (6.4%), and post-traumatic stress (5.7%) were the three main problems reported. Of this subsample, 56.7% reported using a legal or illegal drug without SUD, 5.4% reported SUD at one time on alcohol, 0.8% on tobacco, and 1.3% on medical or illegal drugs, 15.9% reported symptoms related to mental health, and 2.9% comorbidity. The prevalence found is consistent with those reported in previous studies, except for an increase in post-traumatic stress, which is consistent with the country’s increase in trauma. |
format | Online Article Text |
id | pubmed-9961066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99610662023-02-26 The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort Medina-Mora, María Elena Genis-Mendoza, Alma Delia Villatoro Velázquez, Jorge Ameth Bustos-Gamiño, Marycarmen Bautista, Clara Fleiz Camarena, Beatriz Martínez-Magaña, José Jaime Nicolini, Humberto Int J Environ Res Public Health Review There is little recent information about the prevalence of symptomatology of mental health disorders in representative population samples in Mexico. To determine the prevalence of mental health symptoms in Mexico and its comorbidity with tobacco, alcohol, and drug use disorder (SUD), we used the 2016–17 National Survey of Drug, Alcohol, and Tobacco Use (Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco, ENCODAT 2016–2017). The data were collected from households using a cross-sectional, stratified, multistage design, with a confidence level of 90% and a response rate of 73.6%. The final sample included 56,877 completed interviews of individuals aged 12–65, with a subsample of 13,130 who answered the section on mental health. Symptoms of mania and hypomania (7.9%), depression (6.4%), and post-traumatic stress (5.7%) were the three main problems reported. Of this subsample, 56.7% reported using a legal or illegal drug without SUD, 5.4% reported SUD at one time on alcohol, 0.8% on tobacco, and 1.3% on medical or illegal drugs, 15.9% reported symptoms related to mental health, and 2.9% comorbidity. The prevalence found is consistent with those reported in previous studies, except for an increase in post-traumatic stress, which is consistent with the country’s increase in trauma. MDPI 2023-02-10 /pmc/articles/PMC9961066/ /pubmed/36833803 http://dx.doi.org/10.3390/ijerph20043109 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Medina-Mora, María Elena Genis-Mendoza, Alma Delia Villatoro Velázquez, Jorge Ameth Bustos-Gamiño, Marycarmen Bautista, Clara Fleiz Camarena, Beatriz Martínez-Magaña, José Jaime Nicolini, Humberto The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort |
title | The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort |
title_full | The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort |
title_fullStr | The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort |
title_full_unstemmed | The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort |
title_short | The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort |
title_sort | prevalence of symptomatology and risk factors in mental health in mexico: the 2016–17 encodat cohort |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961066/ https://www.ncbi.nlm.nih.gov/pubmed/36833803 http://dx.doi.org/10.3390/ijerph20043109 |
work_keys_str_mv | AT medinamoramariaelena theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT genismendozaalmadelia theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT villatorovelazquezjorgeameth theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT bustosgaminomarycarmen theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT bautistaclarafleiz theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT camarenabeatriz theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT martinezmaganajosejaime theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT nicolinihumberto theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT medinamoramariaelena prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT genismendozaalmadelia prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT villatorovelazquezjorgeameth prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT bustosgaminomarycarmen prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT bautistaclarafleiz prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT camarenabeatriz prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT martinezmaganajosejaime prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort AT nicolinihumberto prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort |